Immunotherapy for pancreatic cancer - Science driving clinical progress

Research output: Contribution to journalReview articlepeer-review

Abstract

The identification of key signalling pathways involved in immune-system regulation, along with the development of early pancreatic tumours in mouse models have provided new opportunities for pancreatic cancer treatment and prevention. Immunotherapy for pancreatic cancer is one approach that is at a crucial crossroads, as therapeutics that are designed to target pancreatic-cancer-associated antigens and regulatory signalling molecules are entering clinical trials.

Original languageEnglish (US)
Pages (from-to)459-467
Number of pages9
JournalNature Reviews Cancer
Volume5
Issue number6
DOIs
StatePublished - Jun 1 2005

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Immunotherapy for pancreatic cancer - Science driving clinical progress'. Together they form a unique fingerprint.

Cite this